AB 411
Revises provisions relating to prescription drugs. (BDR 54-1100)
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill modifies Nevada’s regulations regarding prescription drug labeling. It allows a prescribing practitioner to request that the label for mifepristone, misoprostol, or their generic alternatives include the name of the prescribing health care practice instead of the individual practitioner’s name. The bill maintains existing requirements for other prescriptions, ensuring clear labeling with practitioner and patient information. This change aims to provide greater privacy for healthcare practices.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.